Chembio Diagnostics
As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit
While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players.
GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings
GenMark said it intends to use the proceeds for general corporate purposes that may include an expansion of its menu and increasing its manufacturing capacity.
FIND Awards Grants for Development of HCV Dx Tests
Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.
Chembio Lands $550K Grant to Develop POC Zika Assay
The grant is the second in the last six months that the Paul G. Allen Family Foundation has awarded to Chembio for diagnostics development.
Paul G. Allen Ebola Program Awards $6.9M for Ebola Diagnostics
Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.